Intelligence Platform

Patents

Browse 120 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6576614

Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6573259

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 03 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6548055

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6517839

Methods for inducing interleukin-12 and a type1/Th1 T-cell response

The Regents of the University of California · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6423840

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6420522

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6407080

N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6365768

Interleukin-1 and tumor necrosis factors-&agr; modulators, syntheses of said modulators an

The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6350741

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329365

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6294169

Interleukin-1 beta converting enzyme like apoptotic protease-6

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6258948

Inhibitors of Interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 10 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6251878

Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotectiv

The Board of Regents of the University of Texas System · Granted Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6239268

Interleukin-1 type 3 receptors

Neurocrine Biosciences, Inc. · Granted Tue May 29 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6204261

Inhibitors of interleukin-1.beta. Converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6191269

Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-

The Regents of the University of California · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6190656

Immunologic enhancement with intermittent interleukin-2 therapy

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6162800

N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6162790

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6121266

Pyridazines as interleukin-1.beta. converting enzyme inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6103711

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6083503

Interleukin-2 stimulated T lymphocyte cell death for the treatment of autoimmune diseases,

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063371

Pharmaceutical compositions comprising a soluble interleukin-4 receptor

The United States of America as represented by the Secretary of the Army · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6025147

Inhibitors of interleukin-1 .beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired